Lazard Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.7M | Sell |
1,126,910
-1,784
| -0.2% | -$125K | 0.11% | 160 |
|
|
2025
Q1 | $83M | Buy |
1,128,694
+210,028
| +23% | +$15.4M | 0.13% | 134 |
|
|
2024
Q4 | $60.2M | Sell |
918,666
-242,203
| -21% | -$15.9M | 0.09% | 172 |
|
|
2024
Q3 | $90.4M | Sell |
1,160,869
-759,767
| -40% | -$59.2M | 0.12% | 131 |
|
|
2024
Q2 | $150M | Buy |
1,920,636
+1,437,904
| +298% | +$112M | 0.19% | 104 |
|
|
2024
Q1 | $32.7M | Buy |
482,732
+128,616
| +36% | +$8.71M | 0.04% | 291 |
|
|
2023
Q4 | $23.8M | Buy |
354,116
+70,557
| +25% | +$4.75M | 0.03% | 351 |
|
|
2023
Q3 | $19.2M | Buy |
283,559
+124,513
| +78% | +$8.43M | 0.03% | 389 |
|
|
2023
Q2 | $11.4M | Buy |
159,046
+49,908
| +46% | +$3.57M | 0.01% | 532 |
|
|
2023
Q1 | $7.57M | Buy |
109,138
+105,276
| +2,726% | +$7.31M | 0.01% | 648 |
|
|
2022
Q4 | $260K | Buy |
3,862
+494
| +15% | +$33.3K | ﹤0.01% | 1250 |
|
|
2022
Q3 | $183K | Hold |
3,368
| – | – | ﹤0.01% | 1288 |
|
|
2022
Q2 | $221K | Sell |
3,368
-364
| -10% | -$23.9K | ﹤0.01% | 1256 |
|
|
2022
Q1 | $246K | Sell |
3,732
-53,933
| -94% | -$3.56M | ﹤0.01% | 1220 |
|
|
2021
Q4 | $3.36M | Sell |
57,665
-755,118
| -93% | -$44M | ﹤0.01% | 850 |
|
|
2021
Q3 | $48.8M | Buy |
812,783
+636,575
| +361% | +$38.2M | 0.06% | 287 |
|
|
2021
Q2 | $10.6M | Buy |
+176,208
| New | +$10.6M | 0.01% | 590 |
|
|
2016
Q3 | – | Sell |
-363
| Closed | -$10K | – | 986 |
|
|
2016
Q2 | $10K | Buy |
+363
| New | +$10K | ﹤0.01% | 954 |
|
|
2016
Q1 | – | Sell |
-30
| Closed | -$1K | – | 1037 |
|
|
2015
Q4 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 1069 |
|
|
2013
Q3 | – | Sell |
-118
| Closed | -$2K | – | 957 |
|
|
2013
Q2 | $2K | Buy |
+118
| New | +$2K | ﹤0.01% | 1007 |
|